Effects of phosphated titanium and enamel matrix derivatives on osteoblast behavior in vitro

International Journal of Oral and Maxillofacial Implants

Volumn 22, Issue 5, 2007, Pages 701-709

  Dacy, J Anthony ^a   Spears, Robert ^a   Hallmon, William W ^a   Kerns, David G ^a   Rivera Hidalgo, Francisco ^a   Minevski, Zoran S ^b   Nelson, Carl J ^b   Opperman, Lynne A ^a  

^a BAYLOR COLLEGE OF DENTISTRY   (United States)

^b Lynntech   (United States)

Author keywords

Enamel matrix derivatives; Interleukin 1 ; Osteoblasts; Phosphate titanium; Transforming growth factor 1

Indexed keywords

ALLOY; BIOMATERIAL; ENAMEL MATRIX PROTEINS; ENAMEL PROTEIN; INTERLEUKIN 1BETA; TITANIUM; TITANIUM ALLOY (TIAL6V4); TITANIUM PHOSPHATE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BONE DEVELOPMENT; CELL ADHESION; CELL CULTURE; CULTURE MEDIUM; DRUG EFFECT; ELECTRON PROBE MICROANALYSIS; OSTEOBLAST; PATHOLOGY; RAT; SCANNING ELECTRON MICROSCOPY; SPRAGUE DAWLEY RAT; SURFACE PROPERTY; TIME;

ALLOYS; ANIMALS; BIOCOMPATIBLE MATERIALS; CELL ADHESION; CELLS, CULTURED; CULTURE MEDIA; DENTAL ENAMEL PROTEINS; ELECTRON PROBE MICROANALYSIS; INTERLEUKIN-1BETA; MICROSCOPY, ELECTRON, SCANNING; OSTEOBLASTS; OSTEOGENESIS; RATS; RATS, SPRAGUE-DAWLEY; SURFACE PROPERTIES; TIME FACTORS; TITANIUM; TRANSFORMING GROWTH FACTOR BETA1;

EID: 35648972096     PISSN: 08822786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Karoussis IK, Salvi GE, Heitz-Mayfield UA,Bragger U, Hämmerle CHF, Lang NP. Long-term implant prognosis in patients with and without a history of chronic periodontitis: A 10-year prospective cohort study of the ITI Dental Implant System. Clin Oral Implant Res 2003;14:329-339.
2. De Bruyn H, Collaert B.The effect of smoking on early implant failure.Clin Oral Implants Res 1994;5:260-264.
3. Bain CA. Smoking and implant failure-Benefits of a smoking cessation protocol. Int J Oral Maxillofac Implants 1996;11: 756-759.
4. Olson JW, Shernoff AF, Tarlow JL, Colwell JA, Scheetz JP, Bingham SF. Dental endosseous implant assessments in type 2 diabetic populations prospective study. Int J Oral Maxillofac Implants 2000;15:811-818.
5. Morris HF, Ochi S, Winkler S. Implant survival in patients with type 2 diabetes: Placement up to 36 months. Ann Periodontol 2000;5:157-165.
6. Guizzardi S, Galli C, Martini D, et al. Different titanium surface treatment influences human mandibular osteoblast response. J Periodontol 2004;75:273-282.
7. Nelson CJ, Minevski ZS, Urban RM, Turner TM, Jacobs JJ.Corrosion and wear resistant bioactive surgical implants. In: Proceedings from ASM Materials and Processes for Medical Devices Conference, Anaheim, CA, September 8-10, 2003.
8. Heyden R, Schmid J, Schaefer EM. Bones and bone tissue. In: Marieb EN, Hoehn K (eds). Human Anatomy and Physiology, ed 7. Reading, MA: Benjamin-Cummings, 2006.
9. Park YG, Kang SK, Kim WJ, Lee YC, Kim CH. Effects of TGF-beta, TNF-alpha, IL-beta and IL-6 alone or in combination, and tyrosine kinase inhibitor on cyclooxygenase expression, prostaglandin E2 production and bone resorption in mouse calvarial bone cells. Int J Biochem Cell Biol 2004;36: 2270-2280.
10. Tokoro Y, Yamamoto T, Hara K. IL-1β mRNA as the predominant inflammatory cytokine transcript: Correlation with inflammatory cell infiltration into human gingiva. J Oral Pathol Med 1996;25:225-231.
11. Stashenko P, Fujiyoshi P, Obernesser MS, Prostak L, Haffajee AD, Socransky SS. Levels of IL-1β in tissue from sites of active periodontal disease. J Clin Periodontol 1991;18:548-554.
12. Tsai CC, Ho YP, Chen CC Levels of IL-1β and IL-8 in gingival crevicular fluids in adult periodontitis. J Periodontol 1995; 66:852-859.
13. Kao RT, Curtis DA, Richards DW, Preble J. Increased IL-1β in the crevicular fluid of diseased implants. Int J Oral Maxillofac Implants 1995;10:696-701.
14. Panagakos FS, Aboyoussef H.Dondero R, Jandinski JJ. Detection and measurement of inflammatory cytokines in implant crevicular fluid: A pilot study. Int J Oral Maxillofac Implants 1996;11:794-799.
15. Curtis DA, Kao R, Plesh O, Finzen F, Franz L Crevicular fluid analysis around two failing dental implants: A clinical report. J Prosthodont 1997;6:210-214.
16. Hauschka PV, Mavrakos AE, lafrati M, Doleman SE, Klagsbrun M. Growth factors in bone matrix: Isolation of multiple layers of bone types by affinity chromatography on heparin sepharose. J Biol Chem 1986;261:12665-12674.
17. Robey PG, Young MF, Flanders KC, et al. Osteoblasts synthesize and respond to transforming growth factor-type beta. J Cell Biol 1987;105:457-463.
18. Chenu C, Pfeilschifter J, Mundy GR, Roodman GD.Transforming growth factor-beta inhibits formation of osteoclast-like cells in long-term human marrow studies. Proc Natl Acad Sci 1988;85:5683-5687.
19. Rosen DM, Stempien SA, Thompson AY, Seyedin SM.Transforming growth factor-beta modulates the expression of osteoblast and chondroblast phenotypes in vitro. J Cell Physiol 1988;134:337-346.
20. Shinar DM, Rodan G. Biphasic effects of transforming growth factor-beta on the production of osteoclast-like cells in mouse bone marrow cultures:The role of prostaglandins in the generation of these cells. Endocrinology 1990;126: 3153-3158.
21. Strong DD, Beacher AL, Wergedal JE, Linkhart TA. Insulin-like growth factor II and transforming growth factor-beta regulate collagen expression in human osteoblast-like cells in vitro. J Bone Miner Res 1991:6:15-23.
22. Skaleric U, Kramar B, Petelin M, Pavica Z.Wahl SM.Changes in TGF-β1 levels in gingival crevicular fluid and serum associated with periodontal inflammation associated in humans and dogs. Eur J Oral Sci 1997;105:136-142.
23. Trasatti C, Spears R, Gutmann JL, Opperman LA. Increased TGF-β1 production by rat osteoblasts In the presence of Pepgen P-15 in vitro. J Endod 2004;30:213-217.
24. Oreffo RO, Mundy GR, Seyedin SM, Bonewald L. Activation of the bone-derived latent TGF-β complex by isolated osteoclasts. Biochem Biophys Res Commun 1989;158:817-823.
25. Espevik T, Figari IS, Shalaby R, et al. Inhibition of cytokine production by cyclosporine A and transforming growth factor beta. J Exp Med 1987;166:571-576.
26. Hammarström L, HeijI L, Gestrelius S. Periodontal regeneration in a buccal dehiscence model in monkeys after application of enamel matrix proteins.J Clin Periodontol 1997;24:669-677.
27. Sculean A, Donos N, Blaes A, Lauermann M, Reich E, Brecx M. Comparison of enamel matrix proteins and bioabsorbable membranes in the treatment of intrabony periodontal defects. A split-mouth study.J Periodontol 1999;70:255-262.
28. Heijl L. Periodontal regeneration with enamel matrix derivative in one human experimental defect. A case report. J Clin Periodontol 1997;24:693-696.
29. Mizutani S, Tsuboi T, Tazoe M, Koshihara Y, Goto S, Togari A. Involvement of FGF-2 in the action of Emdogain on normal human osteoblast activity.Oral Dis 2003;9:210-217.
30. Shimizu-Ishiura M, Tanaka S, Lee WS, Debari K, Sasaki T. Effects of enamel matrix derivative to titanium implantation in rat femurs. J Biomed Mater Res 2002;60:269-276.
31. Casati M, Sallum E, Nociti F,Caffesse R, Sallum A. Enamel matrix derivative and bone healing after guided tissue regeneration in dehiscence-type defects around implants. A histomorphometric study in dogs. J Periodontol 2002;73:789-796.
32. Franke Stenport V, Johansson CB. Enamel matrix derivative and titanium Implants. An experimental pilot study in the rabbit.J Clin Periodontol 2003;30:359-363.
33. Williams DC, Boder GB,Toomey RE, et al. Mineralization and metabolic response in serially passaged adult rat bone cells. Calcif Tissue Int 1980;30:233-246.
34. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-275.
35. Viornery C, Guenther HL, Aronsson BO, Péchy P, Descouts P, Grätzel M. Osteoblast culture on polished titanium disks modified with phosphonic acids.J Biomed Mater Res 2002;62: 149-155.
36. Siato H.Tsujitani S, Oka S, et al.The expression of TGF-β1 is significantly correlated with the expression of VEGF and poor prognosis of patients with advanced gastric carcinoma. Cancer 1999;86:1455-1462.
37. Cornelini R, Rubini C, Fioroni M, Favero GA, Strocchi R, Piattelli A.TGF-β1 expression in the perl-implant soft tissues of healthy and falling dental implants. J Periodontol 2003;74: 446-450.
38. Okubo K, Kobayashi M,Takiguchi T, et al. Participation of endogenous IGF-I and TGF-β1 with enamel matrix derivativestimulated cell growth in human periodontal ligament cells. J Periodont Res 2003;38:1-9.
39. Lyngstadaas SP, Lundberg E, Ekdahl H.Andersson C,Gestrelius S. Autocrine growth factors in humal periodontal ligament cells cultured on enamel matrix derivative. J Clin Periodontal 2001;28:181-188.
40. Gestrelius S, Andersson C, Linström D, Hammarström L, Somerman M. In vitro studies on periodontal ligament cells and enamel matrix derivative. J Clin Periodontol 1997;24: 685-692.
41. Schwarz F, Rothamel D, Herten M, Sculean A, Scherbaum W, Becker J. Effect of enamel matrix derivative on the attachment, proliferation, and viability of human SaOs(2) osteoblasts on titanium implants.Clin Oral Investig 2004;8:165-171.